News Category
NanoViricides' regulatory approval to test its oral antiviral NV-387 in a Phase II Ebola trial in the DRC marks a potential shift toward more accessib...
New research from the University of Virginia suggests focused ultrasound could enhance drug delivery to gliomas, offering a less harmful alternative t...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in prostate and triple-negative breast can...
A new narrative review in the World Journal of Pediatric Surgery provides a comprehensive framework for risk-adapted management of neuroblastoma, emph...
Quantum BioPharma advances a two-pronged approach to neurological health, with Lucid-MS for multiple sclerosis and unbuzzd for alcohol misuse, highlig...
A Spanish patient's brain cancer scare was ultimately diagnosed as pork tapeworm cysts, underscoring the importance of proper pork preparation and the...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate program and expanded its patent portfolio, strengthening its position in ne...
The Keep A Breast Foundation's 2026 High Desert Collection pairs local artists with chest casts to spark conversations about breast health, launching ...
A novel liquid biopsy offers a simpler method to predict immunotherapy response in advanced lung cancer patients, potentially aiding clinical trials f...
GeoVax announces completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA vaccine, positioning it for a pivotal P...
Onco-Innovations' integrated approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI could improve cancer treatment efficacy an...
Researchers at Nagoya University discovered that the ancient protein C3, when produced by tumor cells, boosts the effectiveness of immunotherapy, offe...
VolitionRx's new Capture-Seq technology, described in a peer-reviewed paper, isolates over 99% pure ctDNA, potentially enabling earlier cancer detecti...
VERAXA Biotech's VXA-222 bsADC program moves past discovery phase, and the company expands its IP portfolio with new patent filings, reinforcing its o...
The American Heart Association's annual recognition program highlights hospitals and EMS agencies that adhere to evidence-based guidelines, underscori...
The United States has recorded its highest number of measles cases in three decades, prompting health officials to intensify contact tracing and vacci...
Oncotelic Therapeutics' upcoming presentation at the OTCQB Virtual Investor Conference underscores its progress in clinical trials, platform validatio...
GeoVax underscores the strategic value of its MVA-based filovirus vaccine portfolio following independent research suggesting cross-reactive immune re...
Amber Dermatology, a new practice founded by Dr. Alyssa Miceli, opens in Trumbull, CT, aiming to transform dermatologic care with a patient-centered, ...
Experts warn that climate change is accelerating the spread of infectious diseases, yet policymakers are not treating this threat with sufficient urge...
VERAXA Biotech has appointed Dr. Christoph Erkel as Chief Scientific Officer to lead scientific strategy for its proprietary BiTAC® cancer therapy pla...
Onco-Innovations closed a CAD$5 million private placement to fund its ONC010 program and SynoGraph platform development, addressing a critical need fo...
Dr. Lee Newcomer, a former UnitedHealthcare chief medical officer and author of 'UNMASKED', has signed with Creative Management Partners agent Alan Mo...
A preclinical study reveals an experimental therapy containing vitamin B12 may halt glioblastoma multiforme, the deadliest brain cancer, complementing...
VolitionRx (NYSE American: VNRX) emphasizes mounting clinical evidence supporting its Nu.Q NETs assay as a biomarker for sepsis, with studies showing ...
VERAXA Biotech announced it has expanded its patent portfolio to over 50 granted patents across 14 countries, protecting its BiTAC-TCE and BiTAC-ADC p...
VERAXA Biotech strengthens its scientific leadership by appointing antibody therapeutics specialist Dr. Christoph Erkel as CSO, as the company advance...
VERAXA Biotech AG filed new patent applications for its BiTAC-TCE and BiTAC-ADC platforms, expanding its IP portfolio to over 50 granted patents acros...
Dr. Edward H. Davidson, a board-certified plastic surgeon at Palm Beach Plastic Surgery Institute, has been recognized as a 2026 Castle Connolly Top D...
Researchers plan to investigate the role of autoantibodies in cancer risk and immune response, which could explain why some individuals with risk fact...
Lantern Pharma's EMA clearance for a Phase 1b/2 trial of LP-184 in biomarker-selected bladder cancer patients marks a key step in advancing its AI-dri...
The global flow cytometry diagnostics market is projected to grow from USD 1.5 billion in 2026 to USD 3.5 billion by 2036, driven by increasing demand...
GeoVax reported a net loss of $4.4 million for Q2 2026, down from $5.4 million a year ago, and highlighted progress toward initiating a pivotal immuno...
Onco-Innovations Limited is progressing its lead PNKP inhibitor ONC010 through manufacturing, formulation, and regulatory steps, aiming to disrupt can...
Research in Nature Medicine indicates experimental immunotherapy may improve outcomes for children with aggressive brain and spinal cord tumors, while...
VERAXA Biotech AG and OmniAb have reached a key milestone in their collaboration, advancing VXA-222, a bispecific antibody-drug conjugate designed to ...
Onco-Innovations combines a novel DNA repair target (PNKP), nanoparticle delivery, and AI via SynoGraph to potentially overcome drug resistance, trial...
VERAXA Biotech AG appoints Christoph Erkel as CSO to lead development of its BiTAC platform for solid tumor cancer therapies, signaling a strategic pu...
VERAXA Biotech has received Scientific Advice from Germany's Paul-Ehrlich-Institute supporting the development strategy for its lead BiTAC®-TCE candid...
Onco-Innovations Ltd. is advancing ONC010, a nanoparticle-encapsulated PNKP inhibitor for biomarker-selected cancers, aligning with the shift toward p...
Dr. Monica Gandhi of UCSF notes that recent outbreaks of measles, mpox, and HIV have revealed weaknesses in public health systems, while companies lik...
Lantern Pharma (NASDAQ: LTRN) received a U.S. patent allowance for methods using a three-gene biomarker signature to select patients for its investiga...
VERAXA Biotech AG has appointed Christoph Erkel as CSO to lead the development of its BiTAC platform for solid tumor cancer therapies, leveraging his ...
iOrganBio expands its Scientific Advisory Board with stem cell and neuroscience expert Lee L. Rubin, Ph.D., aiming to enhance its CellForge platform f...
Quantum BioPharma is advancing a two-pronged approach to address multiple sclerosis and alcohol intoxication, with its lead candidate Lucid-MS enterin...
Oncotelic Therapeutics announced the publication of preclinical data for its intravenous everolimus formulation Sapu003, which could overcome oral dru...
A new study reveals that the ratio of polyunsaturated to monounsaturated fats may affect immune cell membrane composition and susceptibility to ferrop...
Kairos Pharma has partnered with Bayer to test its antibody ENV-105 with XOFIGO in metastatic castration-resistant prostate cancer, potentially offeri...
